BIOMAT Database Logo BIOMAT Database Logo

Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma. 1999

N Konishi, and S Nakaoka, and K Matsumoto, and M Nakamura, and S Kuwashima, and Y Hiasa, and M Cho, and H Uemura, and Y Hirao
Second Department of Pathology, Nara Medical University, Kashihara, Japan. nkonishi@naramed-u.ac.jp

The expression of pepsinogen II (PG II), an aspartyl proteinase usually involved in the digestion of proteins in the stomach, was immunohistochemically investigated in conjunction with androgen (AR) and estrogen receptor (ER) status in prostate adenocarcinomas. Of a total of 38 samples obtained from radical prostatectomies, 23 tumors (60.5%) were positive for PG II and there was a significant positive correlation to the expression of AR but not to ER. Cells positive for PG II were localized mainly to the peripheral zones of tumorous glands which, in normal prostate, are negative, and in areas also expressing AR. In addition, a significant correlation between AR and ER was detected in the prostate carcinomas examined, which suggests a hormone-dependent status. On the basis of these results, PG II expression might be closely related to hormonal alterations associated with the development of prostate tumors.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

N Konishi, and S Nakaoka, and K Matsumoto, and M Nakamura, and S Kuwashima, and Y Hiasa, and M Cho, and H Uemura, and Y Hirao
Intranuclear distribution of androgen receptors in human prostate carcinoma.
January 1987, The Journal of endocrinology,
N Konishi, and S Nakaoka, and K Matsumoto, and M Nakamura, and S Kuwashima, and Y Hiasa, and M Cho, and H Uemura, and Y Hirao
Expression of Androgen and Estrogen Receptors in the Human Lacrimal Gland.
March 2023, International journal of molecular sciences,
N Konishi, and S Nakaoka, and K Matsumoto, and M Nakamura, and S Kuwashima, and Y Hiasa, and M Cho, and H Uemura, and Y Hirao
[Expression of estrogen receptors alpha and beta, androgen receptors and progesterone receptors in human cornea].
September 2002, Nippon Ganka Gakkai zasshi,
N Konishi, and S Nakaoka, and K Matsumoto, and M Nakamura, and S Kuwashima, and Y Hiasa, and M Cho, and H Uemura, and Y Hirao
Androgen, estrogen, and progesterone receptors in peripheral and central zones of human prostate with adenocarcinoma.
May 1983, Urology,
N Konishi, and S Nakaoka, and K Matsumoto, and M Nakamura, and S Kuwashima, and Y Hiasa, and M Cho, and H Uemura, and Y Hirao
[Androgen, progestin and estrogen receptors in the normal human prostate and in pathology].
January 1984, Sovetskaia meditsina,
N Konishi, and S Nakaoka, and K Matsumoto, and M Nakamura, and S Kuwashima, and Y Hiasa, and M Cho, and H Uemura, and Y Hirao
Expression of androgen, estrogen and progesterone receptors in mucinous carcinoma of the breast.
May 2008, The Kaohsiung journal of medical sciences,
N Konishi, and S Nakaoka, and K Matsumoto, and M Nakamura, and S Kuwashima, and Y Hiasa, and M Cho, and H Uemura, and Y Hirao
Expression of androgen and estrogen receptors in human scalp mesenchymal cells in vitro.
March 2007, Archives of dermatological research,
N Konishi, and S Nakaoka, and K Matsumoto, and M Nakamura, and S Kuwashima, and Y Hiasa, and M Cho, and H Uemura, and Y Hirao
Progesterone receptor in hepatocellular carcinoma. Correlation with androgen and estrogen receptors.
May 1991, Cancer,
N Konishi, and S Nakaoka, and K Matsumoto, and M Nakamura, and S Kuwashima, and Y Hiasa, and M Cho, and H Uemura, and Y Hirao
The role of estrogen, androgen and progestogen receptors in the management of carcinoma of the prostate.
January 1979, Transactions of the American Association of Genito-Urinary Surgeons,
N Konishi, and S Nakaoka, and K Matsumoto, and M Nakamura, and S Kuwashima, and Y Hiasa, and M Cho, and H Uemura, and Y Hirao
Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver.
September 1991, Digestive diseases and sciences,
Copied contents to your clipboard!